Share
Despite political and economic uncertainties, healthcare remains a lucrative investment space. However, growing concerns around government spending cuts on Medicare, Medicaid, and medical research could impact investment flows. Additionally, tariffs and high interest rates may influence deal valuations and financing conditions. Despite these risks, experts believe healthcare's fundamental value proposition—driven by necessity and innovation—will keep it attractive to investors in the long run.
Rob Larson was interviewed by Termgrid and shared his thoughts on the role and value of tech-enabled services, as well as some thoughts on the overall state of the market.
Read More
A recap of Grant Thornton Stax and Raymond James’ healthcare breakfast on PE investment opportunities across the pharma tech ecosystem.
AI is driving a bifurcation between surface-layer productivity tools and core operational platforms within vertical software. Learn how Ai is reshaping vertical SaaS here.
For four straight years, Grant Thornton Stax has earned a spot on the Vault Consulting Top 50 list of the best consulting firms to work for in North America. Read more here.
Grant Thornton Stax supported Alma, a membership-based platform that aids mental health clinicians in building thriving private practices, on its recent acquisition by Spring Health. Read more.
Grant Thornton Stax is pleased to announce our 2026 winter promotions. Click to learn more.
Grant Thornton Stax Consultant Chris Flynn sits down for a Q&A to share his experience and insights from his tenure with our firm. Read the full interview here.